Pharmyn ApS: Financial statements 2019
CVR: 37133892
Pharmyn ApS (CVR 37133892) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 108 and a net result of DKK 0 compared with DKK 88 the year before. That is a decrease of 62.5% compared with the year before. Equity amounted to DKK 42,379. The solvency ratio was 84%. The company had 1 employee in the financial year.
- Gross Profit
- 108 kr.
- Profit/Loss
- 0 kr.
- Equity
- 42,379 kr.
- Total Assets
- 50,479 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 108 | 0 | 42 t. | 1 |
| 2018 | - | 288 | 88 | 42 t. | 0 |
| 2017 | - | -4 t. | -4 t. | 42 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2019
Pharmyn ApS has published its annual report for 2018. Gross profit came to DKK 288, and the net result was DKK 88.
About Pharmyn ApS
Pharmyn ApS is a Danish company of the type Anpartsselskab based in Kolding, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Henrik Lund Uth. The company is owned by Henrik Lund Uth. In 2025, the company reported a gross profit of DKK -12,457 and a net result of DKK -12,409 compared with DKK 6,701 the year before. Equity amounted to DKK 18,662.
